ReadCoor
Cambridge, US · Founded 2016 · Delaware corporation · 2,439 employees on LinkedIn · 4 known investors
Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform. It serves researchers analyzing gene expression at subcellular resolution, including in FFPE and degraded samples.
Founders & leadership
ReadCoor was founded in 2016 by Evan Daugharthy.
ED
Evan DaugharthyCofounder30 Under 30 2015
RT
Richard TerryExecutive
Board
YT
VT
Victor TongBoard director
TG
Thomas GroganBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$52.4M disclosed across 3 rounds · 2016–2019
▶$26.8MraisedOct 2019 · 4 investors · Other Health CareRule 506(b)
▶$26.8MraisedOct 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas GroganDirector
- Victor TongDirector
- Richard TerryExecutive Officer, Director
- Offering amount
- $30.1M
- Amount sold
- $26.8M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$2.6MraisedJul 2019 · 1 investors · Other Health CareRule 506(b)
▶$2.6MraisedJul 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yuh-Geng TsayDirector
- Thomas GroganDirector
- Victor TongDirector
- Richard TerryExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.6M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$23MraisedSep 2016 · 5 investors · Other Health CareRule 506(b)
▶$23MraisedSep 2016 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yuh-Geng TsayDirector
- Victor TongDirector
- Richard TerryExecutive Officer, Director
- Shawn MarcellExecutive Officer, Director
- Offering amount
- $23M
- Amount sold
- $23M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does ReadCoor do?
- Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform. It serves researchers analyzing gene expression at subcellular resolution, including in FFPE and degraded samples.
- Who founded ReadCoor?
- ReadCoor was founded by Evan Daugharthy in 2016.
- Who are ReadCoor's investors?
- ReadCoor's investors include LAV, Lilly Asia Ventures, Lilly Ventures, Vivo Capital.
- How much funding has ReadCoor raised?
- ReadCoor has disclosed $52.4M raised across 3 rounds.
- Where is ReadCoor headquartered?
- ReadCoor is headquartered in Cambridge, US.